| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 773-779, Copyright © 1996 by Endocrine Society
ARTICLES |
Y Ito, T Kobayashi, T Kimura, N Matsuura, E Wakasugi, T Takeda, T Shimano, Y Kubota, T Nobunaga, Y Makino, C Azuma, F Saji and M Monden
Department of Surgery, Osaka University Medical School, Japan.
The expression of the oxytocin (OT) receptor (OTR) in breast cancer was studied using newly established anti-OTR monoclonal antibodies. Immunoblotting indicated that the antibody 2F8 recognized a 70K OTR in the pregnant myometrium and breast cancer tissue. Among 57 breast cancer patients, we detected OTR immunoreactivity in 52 (91.2%) by immunohistochemistry using 2F8. Using another monoclonal antibody for different receptor domains, 1-2, the staining profile was identical in all positive samples. Of 52 OTR-positive samples, 28 were diffusely positive (> 80% of cancer cells were stained), and 24 were partially positive (< 80% cells were stained). The ratio of estrogen receptor- positive samples was slightly higher among those that were diffusely positive, but there was no apparent relationship between OTR expression and other clinical parameters. We also confirmed the expression of the OTR in positively stained samples by means of Northern blotting and RT- PCR at the transcription level. The OTR messenger RNA and RT-PCR product were the same size as those in the pregnant myometrium. We also determined the expression of the OTR using flow cytometry in four breast cancer cell lines (MCF-7, MDA-MB-231, MDA-MB-361, and MDA-MB- 468). However, OT had no significant effect on their growth during a short period (7 days) of culture. These findings indicated that the OTR is expressed in breast cancer derived not from the myoepithelium but from the glandular or ductal epithelium; however, the biological function of OT in breast cancer remains to be determined.
This article has been cited by other articles:
![]() |
V. Lollivier, P.-G. Marnet, S. Delpal, D. Rainteau, C. Achard, A. Rabot, and M. Ollivier-Bousquet Oxytocin stimulates secretory processes in lactating rabbit mammary epithelial cells J. Physiol., January 1, 2006; 570(1): 125 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pequeux, C. Breton, J.-C. Hendrick, M.-T. Hagelstein, H. Martens, R. Winkler, V. Geenen, and J.-J. Legros Oxytocin Synthesis and Oxytocin Receptor Expression by Cell Lines of Human Small Cell Carcinoma of the Lung Stimulate Tumor Growth through Autocrine/Paracrine Signaling Cancer Res., August 15, 2002; 62(16): 4623 - 4629. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bussolati and P. Cassoni Editorial: The Oxytocin/Oxytocin Receptor System--Expect the Unexpected Endocrinology, April 1, 2001; 142(4): 1377 - 1379. [Full Text] |
||||
![]() |
G. Gimpl and F. Fahrenholz The Oxytocin Receptor System: Structure, Function, and Regulation Physiol Rev, April 1, 2001; 81(2): 629 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Cho, R. Léveillé, R. Kao, B. Rousset, A. F. Parlow, W. E. Burak Jr., E. L. Mazzaferri, and S. M. Jhiang Hormonal Regulation of Radioiodide Uptake Activity and Na+/I- Symporter Expression in Mammary Glands J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2936 - 2943. [Abstract] [Full Text] |
||||
![]() |
J. F. Novak, M. B. Judkins, M. I. Chernin, P. Cassoni, G. Bussolati, J. A. Nitche, and S. K. Nishimoto A Plasmin-derived Hexapeptide from the Carboxyl End of Osteocalcin Counteracts Oxytocin-mediated Growth of Inhibition of Osteosarcoma Cells Cancer Res., July 1, 2000; 60(13): 3470 - 3476. [Abstract] [Full Text] |
||||
![]() |
J. A. Copland, Y.-J. Jeng, Z. Strakova, K. L. Ives, M. R. Hellmich, and M. S. Soloff Demonstration of Functional Oxytocin Receptors in Human Breast Hs578T Cells and Their Up-Regulation through a Protein Kinase C-Dependent Pathway Endocrinology, May 1, 1999; 140(5): 2258 - 2267. [Abstract] [Full Text] |
||||
![]() |
T. L. Bale and D. M. Dorsa Cloning, Novel Promoter Sequence, and Estrogen Regulation of a Rat Oxytocin Receptor Gene Endocrinology, March 1, 1997; 138(3): 1151 - 1158. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |